Cardiac and coronary consequences of intracoronary platelet activating factor infusion in the domestic pig

D EzraG Z Feuerstein


In previous studies we have shown that platelet-activating factor (PAF) is a potent vasoactive substance with deleterious effects on coronary blood flow (CBF) and myocardial performance. The present study further investigates the effects of PAF during its sustained intracoronary infusion in the blood-perfused domestic pig (n = 16). PAF infusion (1-9 nmol/min) produced triphasic changes in CBF (n = 7): an initial brief phase of coronary dilation (14 +/- 2% above baseline), followed by severe reduction in CBF due to increase in coronary vascular resistance and a third phase of escape that was characterized by return of CBF towards baseline in spite of continuing PAF infusion. In 9 remaining pigs PAF infusion had a biphasic response: the first phase of coronary dilation rapidly turned into severe coronary constriction accompanied by severe systemic hypotension and death within a few min. PAF infusion caused a profound rise in systemic arterial and coronary venous thromboxane B2 levels, while 6-keto-PGF1 alpha and leukotriene C4-immunoreactivity levels were not changed. Indomethacin completely blocked the rise in thromboxane level during PAF infusion and abolished the constrictor effect of PAF on the coronary vessels. These data su...Continue Reading


Jun 28, 1979·Nature·M ChignardJ Benveniste
Oct 29, 1979·Biochemical and Biophysical Research Communications·M L BlankE E Muirhead
Sep 1, 1984·British Journal of Pharmacology·A M LeferJ B Smith
Jun 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·S M PrescottT M McIntyre
Sep 1, 1983·British Journal of Pharmacology·J BenvenisteC Labat
Jan 21, 1983·European Journal of Pharmacology·P BessinJ Benveniste
Mar 1, 1984·The American Journal of Physiology·G FeuersteinR E Goldstein
Jan 1, 1982·Clinical and Experimental Hypertension. Part A, Theory and Practice·G FeuersteinI J Kopin
Jul 1, 1964·Journal of Applied Physiology·J A HERD, A C BARGER

❮ Previous
Next ❯


Nov 1, 1987·Lipids·H K Mangold, N Weber
Dec 1, 1991·Lipids·R RabinoviciG Feuerstein
Jun 1, 1997·Archives of Pharmacal Research·S Y SonH W Chang
May 1, 1984·Prostaglandins·G Feuerstein
Apr 1, 1991·Trends in Cardiovascular Medicine·M R HollandS M Prescott
Mar 1, 1997·Journal of Lipid Mediators and Cell Signalling·G FeuersteinS Vonhof
May 1, 1992·The Journal of Clinical Investigation·R RabinoviciG Feuerstein
Feb 25, 2009·International Journal of Cardiology·Dan ZhaoBao-Feng Yang
May 1, 1992·Circulation Research·S YamanakaK Yamamoto
Jan 1, 1991·Research in Experimental Medicine. Zeitschrift Für Die Gesamte Experimentelle Medizin Einschliesslich Experimenteller Chirurgie·S B FelixW E Berdel
Oct 4, 2000·Physiological Reviews·G MontrucchioG Camussi
Jan 1, 1994·Prostaglandins, Leukotrienes, and Essential Fatty Acids·A M Evangelou

❮ Previous
Next ❯

Related Concepts

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Hereditary Sensory Autonomic Neuropathy

Hereditary Sensory Autonomic Neuropathies are a group of inherited neurodegenerative disorders characterized clinically by loss of sensation and autonomic dysfunction. Here is the latest research on these neuropathies.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Landau-Kleffner Syndrome

Landau Kleffner syndrome (LKS), also called infantile acquired aphasia, acquired epileptic aphasia, or aphasia with convulsive disorder, is a rare childhood neurological syndrome characterized by the sudden or gradual development of aphasia (the inability to understand or express language) and an abnormal electroencephalogram. Discover the latest research on LKS here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.


Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Regulation of Vocal-Motor Plasticity

Dopaminergic projections to the basal ganglia and nucleus accumbens shape the learning and plasticity of motivated behaviors across species including the regulation of vocal-motor plasticity and performance in songbirds. Discover the latest research on the regulation of vocal-motor plasticity here.